BPOM Strengthens Cooperation with China for Health Technology Transfer
The Indonesian Food and Drug Authority (BPOM) has just established a strategic partnership with the National Medical Products Administration (NMPA) of China. This cooperation aims to improve the quality of oversight and the development of the health sector in Indonesia.
The main focus of this partnership is no longer limited to just drug supervision. The scope of cooperation has now been expanded to various important areas, including vaccine development, biological products, and the more efficient provision of pharmaceutical raw materials.
One of Indonesia's primary goals in this partnership is to obtain technology transfer from China. With this exchange of technology, Indonesia is expected to be able to produce medical necessities independently within the country, thereby reducing reliance on imported products.
This step is considered a positive effort by the government to strengthen national health resilience. With more advanced technology, BPOM is expected to be able to guarantee the safety and effectiveness of health products consumed by the Indonesian public according to international standards.
This cooperation is clear evidence of Indonesia's commitment to continue innovating in the pharmaceutical field. It is hoped that the collaboration between BPOM and NMPA will have a long-term impact on the availability of affordable and high-quality medicine for all Indonesian people.